194 related articles for article (PubMed ID: 18815554)
1. Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucose-induced insulin secretion.
Nogueira TC; Anhê GF; Carvalho CR; Curi R; Bordin S; Carpinelli AR
Pancreas; 2008 Oct; 37(3):309-15. PubMed ID: 18815554
[TBL] [Abstract][Full Text] [Related]
2. Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide.
Nogueira TC; Graciano MF; Anhê GF; Curi R; Bordin S; Carpinelli AR
Pancreas; 2009 Jul; 38(5):585-92. PubMed ID: 19295452
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice.
Zawalich WS; Tesz GJ; Zawalich KC
J Endocrinol; 2002 Aug; 174(2):247-58. PubMed ID: 12176663
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism.
El-Kholy W; Macdonald PE; Lin JH; Wang J; Fox JM; Light PE; Wang Q; Tsushima RG; Wheeler MB
FASEB J; 2003 Apr; 17(6):720-2. PubMed ID: 12586735
[TBL] [Abstract][Full Text] [Related]
5. Cellular depletion of atypical PKC{lambda} is associated with enhanced insulin sensitivity and glucose uptake in L6 rat skeletal muscle cells.
Stretton C; Evans A; Hundal HS
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E402-12. PubMed ID: 20530734
[TBL] [Abstract][Full Text] [Related]
6. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo.
Chen YW; Huang CF; Tsai KS; Yang RS; Yen CC; Yang CY; Lin-Shiau SY; Liu SH
Diabetes; 2006 Jun; 55(6):1614-24. PubMed ID: 16731823
[TBL] [Abstract][Full Text] [Related]
7. Role of Islet Glucokinase, Glucose Metabolism, and Insulin Pathway in the Enhancing Effect of Islet Neogenesis-Associated Protein on Glucose-Induced Insulin Secretion.
Maiztegui B; Román CL; Barbosa-Sampaio HC; Boschero AC; Gagliardino JJ
Pancreas; 2015 Aug; 44(6):959-66. PubMed ID: 25906449
[TBL] [Abstract][Full Text] [Related]
8. Wortmannin, a PI3-kinase inhibitor: promoting effect on insulin secretion from pancreatic beta cells through a cAMP-dependent pathway.
Nunoi K; Yasuda K; Tanaka H; Kubota A; Okamoto Y; Adachi T; Shihara N; Uno M; Xu LM; Kagimoto S; Seino Y; Yamada Y; Tsuda K
Biochem Biophys Res Commun; 2000 Apr; 270(3):798-805. PubMed ID: 10772905
[TBL] [Abstract][Full Text] [Related]
9. Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate.
Junkin KA; Dyck DJ; Mullen KL; Chabowski A; Thrush AB
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R944-51. PubMed ID: 19193939
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
11. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line.
Hong SW; Lee J; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Mol Cell Endocrinol; 2012 Oct; 362(1-2):242-52. PubMed ID: 22820130
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals.
Eto K; Yamashita T; Tsubamoto Y; Terauchi Y; Hirose K; Kubota N; Yamashita S; Taka J; Satoh S; Sekihara H; Tobe K; Iino M; Noda M; Kimura S; Kadowaki T
Diabetes; 2002 Jan; 51(1):87-97. PubMed ID: 11756327
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase inhibitors reveal a unique mechanism of enhancing insulin secretion in 832/13 rat insulinoma cells.
Collier JJ; White SM; Dick GM; Scott DK
Biochem Biophys Res Commun; 2004 Nov; 324(3):1018-23. PubMed ID: 15485656
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
[TBL] [Abstract][Full Text] [Related]
15. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
Zawalich WS; Zawalich KC
Endocrinology; 2000 Sep; 141(9):3287-95. PubMed ID: 10965900
[TBL] [Abstract][Full Text] [Related]
16. The phosphatidylinositol/AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo.
Campbell CS; Caperuto LC; Hirata AE; Araujo EP; Velloso LA; Saad MJ; Carvalho CR
Life Sci; 2004 Nov; 76(1):57-70. PubMed ID: 15501480
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ (PKCζ/λ) in 3T3l1 adipocytes.
Manna P; Jain SK
J Biol Chem; 2011 Nov; 286(46):39848-59. PubMed ID: 21953448
[TBL] [Abstract][Full Text] [Related]
18. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
[TBL] [Abstract][Full Text] [Related]
19. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
Lee JW; Swick AG; Romsos DR
Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
[TBL] [Abstract][Full Text] [Related]
20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
